They better cover before volume really picks up, StillBung may crash out on the rocks all red and bloodied here. Tick, Tock, StillBung. See ya later!!
I tried to tell you to buy in here, hope you listened, gonno is a big problem, all 3 trials should be done hopefully end of summer, pending update on IV to oral trial in April. CEMP Freddy and I will be in Martha's Vineyard or St. Maarten Dutch side in a couple years, I think if all three trials pan out we will be significantly higher this year. We also have Takaska, moving along, saving many critter in EU from amputations. It is already safe and effective in EU, bring it to US, soon enough.
Thank you, Doctor, I agree. Thats why I have this company as a major holding in my accounts. Long term.
Really, so you short at $7.20, today? We will remember you.
More like a HGTV Martha Vineyard home coming my way. Critters are too promiscuous is all I am saying; their gonno is my bread and butter (and living quarters) in 6 months and after approval of SOLI (CEO said they want to sell i retail pharmacies, that will be huge, if approved). I may look at St. Marteen.
Officers from AUXL will be free to look for jobs after deal is closed. Adrian Adams is an officer in AUXL, but leading the hunt for new CEO as ACRX BOD leader. He says he wouldn't want to take CEO job at ACRX, but Researcher has eluded to possible announcement of new CEO after the 29th. Could it be Glickman? This is a good pick from Researcher. JMO, maybe then they will announce the results from discussions with FDA on resubmission for Zalviso.
Better than having news every 10 mins like big IBB stocks, 820,000 cases estimated in the US of gonorrea with 25 % resistant (246,000) to Cipro and standard treatments. Only 1 pill of SOLI, killed 100% in Phase 2 study. Results due in Summer. This stock will be heading way higher. See CDC report page 55.
I am up BIG today in a sea of red. Who wants to buy banks, Caterpiller, big chemicals. A lot of the small bios are still fairly cheap. CEMP is rolling, another StillBung short. Drugs save lives, banks perform usury on wallets, why should we bail out those greedy fools when they methodically line their pockets and then go overboard. Oil, supply glut will be around for 6 months.
StillBung is a one man crew, marching with his own drummer, although the drummer is often revealed to be wrong. LOL, ACRX is beginning it's run. StillBung run off.
Maybe by Friday, ENDP deal went through on vote. Closing deal on Jan 29th. Adrian and other management from AUXL will be free to move around. Yes, on 04, they are waiting for the formal payment, which is slow from govt., it should come, though soon enough.
Your source is wrong, 820,000 is the "real" # estimated. Look on page 55 of CDC.gov drugresistance. There are 246,000 resistant cases.
Are you kidding me, 820,000 yearly in US and 23 % resistant to Cipro, and standard treatment. That alone could be $80-$100 million in sales (1 pill gave 100% cure in Phase 2). I am surprised at your analysis, what numbers do you have?
Which will be within six months for CEMP on 2nd trial and Gonorrea trial. If an offer comes, it could be entertained, never know, and it could take several months to work out the contingent details.
TTPH, are they waiting on final trial data, to do a potential deal? Tigacyl is already out there, only by IV, though.
Cemp is different, there is a need for new macrolides with less resistance.
If Dupont and Caterpillar are weak, and banks slow in earnings, bios are the place to be. Many buyouts, CEMP is a good one. JMO, market will open red, maybe some chances to buy the bios. PTX is growing quickly. JMO